Mike McNicholas works as a Consultant Trauma and Knee Surgeon in the UK at Liverpool’s University Hospital Aintree. He is an Honorary Professor in the Directorate of Sport at the University of Salford and Honorary Senior Lecturer, Musculoskeletal Biology Department of the University of Liverpool.
He has a longstanding interest in articular cartilage biology. He regularly lectures and teaches surgical skills in the UK and internationally.
His MD Thesis “Meniscectomy and Osteoarthritis” included collaborative work with Stefan Lohmander on the biological markers of articular cartilage metabolism, comparing these to Nitric Oxide metabolism and received the AANA Richard O’Connor Award. He participated in the ACTIVE and Summit Trials comparing marrow stimulation with cell based treatments. He was a member of the world medical advisory group for arthroscopic MACI. He has worked as a consultant for Schwartz Biomedical for four years and is one of four UK surgeons studying the clinical outcomes of the BioPoly implant, he was the first surgeon to insert the Biopoly racetrack implant. Other current research areas include the effects of delivery method on chondrocyte viability, stem cell augmentation of ACL graft incorporation and novel offloading implants versus osteotomy for the management of the varus arthritic knee.